SOTALOL VERSUS OTHER ANTI-ARRHYTHMIC MEDICATIONS FOR CARDIOVERSION OF ATRIAL FIBRILLATION AND MAINTENANCE OF SINUS RHYTHM: META-ANALYSIS OF RANDOMIZED CONTROLLED STUDIES
According to the 2014 AHA/ACC/HRS guidelines on atrial fibrillation (AF), sotalol has a class I recommendation for use in maintenance of sinus rhythm but there are no recommendations regarding its use for pharmacologic cardioversion in AF.
SOTALOL VERSUS OTHER ANTI-ARRHYTHMIC MEDICATIONS FOR CARDIOVERSION OF ATRIAL FIBRILLATION AND MAINTENANCE OF SINUS RHYTHM: META-ANALYSIS OF RANDOMIZED CONTROLLED STUDIES
Creators
Arun Kanmanthareddy - Creighton University
Madhu Reddy - Creighton University
Venkata Alla - Creighton University
Dixitha Anugula - Creighton University
Vivek Yarlagadda - Creighton University
Pradyumna Agasthi - Creighton University
Madhav Lavu - Creighton University
Sudharani Bommana - Creighton University
Donita Atkins - Creighton University
Claire Hunter - Creighton University
Aryan Mooss - Creighton University
Andrea Natale - Creighton University
Dhanunjaya Lakkireddy - Creighton University
Publication Details
Journal of the American College of Cardiology, Vol.69(11), pp.411-411